← Back to Search

CRC mHealth for Colorectal Cancer Screening

N/A
Recruiting
Led By Samantha L Leaf, Ph.D.
Research Sponsored by ISA Associates, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 6
Awards & highlights

Study Summary

This trial is testing a new program to see if it helps African American men get screened for colorectal cancer. Participants get text messages and videos to help them overcome barriers to screening.

Who is the study for?
This trial is for African American men who aren't up-to-date with colorectal cancer screenings, own a smartphone capable of texting and web access, and speak English. Men with a personal history of colorectal cancer cannot participate.Check my eligibility
What is being tested?
The study tests if an mHealth program on smartphones increases the rate at which African American men get screened for colorectal cancer compared to those who just receive standard CDC educational texts.See study design
What are the potential side effects?
Since this intervention involves information via text messages and does not include medication or medical procedures, there are no direct physical side effects associated with participating in this clinical trial.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 6
This trial's timeline: 3 weeks for screening, Varies for treatment, and month 6 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Receipt of Colorectal Cancer Screening Test at Month 6
Secondary outcome measures
Change from Baseline in Cancer Fatalism at Month 6
Change from Baseline in Colorectal Cancer Knowledge at Month 6
Change from Baseline in Perceived Benefits to Colonoscopy at Month 6
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: CRC mHealth interventionExperimental Treatment1 Intervention
Experimental group participants will have access to the CRC mHealth intervention.
Group II: Control EducationActive Control1 Intervention
Control condition participants will receive information about colorectal cancer and screening developed by the Centers for Disease Control.

Find a Location

Who is running the clinical trial?

ISA Associates, Inc.Lead Sponsor
4 Previous Clinical Trials
691 Total Patients Enrolled
Samantha L Leaf, Ph.D.Principal InvestigatorISA Associates

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this clinical trial permit participation by young adults under 30?

"This medical trial is specifically geared towards adults between the ages of 45 and 75. For younger individuals, there are 38 trials available while 1137 studies cater to older patients."

Answered by AI

Do I meet the qualifications for participating in this study?

"Patients with colorectal cancer between the ages of 45 and 75 are eligible to apply for this medical trial, which is currently accepting up to 158 participants."

Answered by AI

Does this scientific experiment have any open spaces for participation?

"This medical trial, which was first posted on October 1st 2023 and most recently updated September 18th 2023 is not presently seeking new candidates. However, 1148 other studies are actively enrolling participants as of now."

Answered by AI
~101 spots leftby Dec 2024